<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Patient Resource Archives - Heart Valve Voice US</title>
	<atom:link href="https://www.heartvalvevoice-us.org/tag/patient-resource/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.heartvalvevoice-us.org/tag/patient-resource/</link>
	<description>Giving a voice to people with heart valve disease</description>
	<lastBuildDate>Thu, 16 Sep 2021 15:59:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.heartvalvevoice-us.org/wp-content/uploads/2019/02/cropped-Favicon-32x32.png</url>
	<title>Patient Resource Archives - Heart Valve Voice US</title>
	<link>https://www.heartvalvevoice-us.org/tag/patient-resource/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HVVUS Urges Anthem To Revise Coverage Policies</title>
		<link>https://www.heartvalvevoice-us.org/hvvus-urges-anthem-to-revise-coverage-policies/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 26 Jan 2021 19:26:24 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<category><![CDATA[TAVR]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10736</guid>

					<description><![CDATA[<p>Heart Valve Voice US is a patient advocacy organization focused on improving the diagnosis, management and treatment of heart valve disease. We understand Anthem is in the process of reconsidering its current misguided policy of not covering innovative transcatheter valve procedures, such as TAVR for low-risk patients and TEER/TMVR. To the best of our knowledge, [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/hvvus-urges-anthem-to-revise-coverage-policies/">HVVUS Urges Anthem To Revise Coverage Policies</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies</title>
		<link>https://www.heartvalvevoice-us.org/hvvus-expresses-thoughts-on-medicare-coverage-for-innovative-technologies/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 10 Nov 2020 15:56:52 +0000</pubDate>
				<category><![CDATA[Policy Center]]></category>
		<category><![CDATA[Policy Statement]]></category>
		<category><![CDATA[MCIT]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10718</guid>

					<description><![CDATA[<p>Heart Valve Voice US is a nonprofit patient advocacy organization that provides a united voicefor people living with heart valve disease. We advocate for early detection, meaningful support,and timely access to appropriate treatment for all people affected by heart valve disease. Theprimary goal of this proposed rule aligns with our mission and we look forward [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/hvvus-expresses-thoughts-on-medicare-coverage-for-innovative-technologies/">HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>A Busy Fall Ahead for Heart Valve Voice US</title>
		<link>https://www.heartvalvevoice-us.org/a-busy-fall-ahead-for-heart-valve-voice-us/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Wed, 21 Oct 2020 13:03:47 +0000</pubDate>
				<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10712</guid>

					<description><![CDATA[<p>By John Lewis, Executive Director Education and awareness are at the core of our mission as a nonprofit patient advocacy organization. I want to provide you with an update on our recent initiatives that are taking on a new dimension, especially in the areas of research and connecting patients. First, in October we began training [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/a-busy-fall-ahead-for-heart-valve-voice-us/">A Busy Fall Ahead for Heart Valve Voice US</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>FDA Releases Expanded Guidance on Remote Monitoring Devices</title>
		<link>https://www.heartvalvevoice-us.org/fda-releases-expanded-guidance-on-remote-monitoring-devices/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 23 Jun 2020 19:25:51 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10650</guid>

					<description><![CDATA[<p>On June 8, the Food and Drug Administration (FDA) expanded on guidance it released in March that allows additional medical devices to be utilized for remote monitoring for new indications without specific market clearance. In addition to the originally included electrocardiograph (ECG), cardiac monitor, and ECG software device types, the updated guidance would also include [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/fda-releases-expanded-guidance-on-remote-monitoring-devices/">FDA Releases Expanded Guidance on Remote Monitoring Devices</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Heart Valve Voice US Responds to COVID-19 Pandemic</title>
		<link>https://www.heartvalvevoice-us.org/heart-valve-voice-us-responds-to-covid-19-pandemic/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 23 Jun 2020 19:15:32 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10645</guid>

					<description><![CDATA[<p>Heart Valve Voice US has been tracking the impact of COVID-19 on our patient community and has published several guidance documents on the topic of “elective” procedures. We have also called for consistency and transparency in how recommendations for elective procedures are implemented so patients have clarity and can set expectations accordingly. Most recently, we [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/heart-valve-voice-us-responds-to-covid-19-pandemic/">Heart Valve Voice US Responds to COVID-19 Pandemic</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Need for Patient Input Regarding Resumption of Cardiovascular Procedures</title>
		<link>https://www.heartvalvevoice-us.org/need-for-patient-input-regarding-resumption-of-cardiovascular-procedures/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Wed, 06 May 2020 20:21:54 +0000</pubDate>
				<category><![CDATA[Policy Center]]></category>
		<category><![CDATA[Policy Statement]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10582</guid>

					<description><![CDATA[<p>To download this page as a PDF, click here. Heart Valve Voice US is deeply concerned that the patient perspective was omitted from the recent guidance on resuming cardiovascular procedures released in the Journal of American College of Cardiology and endorsed by more than one dozen medical societies. On April 20, 2020, Heart Valve Voice [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/need-for-patient-input-regarding-resumption-of-cardiovascular-procedures/">Need for Patient Input Regarding Resumption of Cardiovascular Procedures</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Guidance for Patients Regarding Elective Procedures</title>
		<link>https://www.heartvalvevoice-us.org/guidance-for-patients-regarding-elective-procedures/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Fri, 24 Apr 2020 17:44:00 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10557</guid>

					<description><![CDATA[<p>To download this page as a PDF, click here. Many medical societies, health systems, and other organizations have issued guidance documents regarding the status of “elective surgeries” during the COVID-19 pandemic. This includes new guidance from the Administration concerning reopening businesses and services and additional guidance from the Centers for Medicare and Medicaid Services (CMS) [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/guidance-for-patients-regarding-elective-procedures/">Guidance for Patients Regarding Elective Procedures</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Covid-19: Advice for individuals with Heart Valve Disease</title>
		<link>https://www.heartvalvevoice-us.org/covid-19-advice-for-individuals-with-heart-valve-disease/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Mon, 23 Mar 2020 14:47:38 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10396</guid>

					<description><![CDATA[<p>COVID-19 (Coronavirus) has presented the world with an unprecedented public health challenge. Its rapid spread has caused significant alarm and disruption across the globe. Understandably, those living with heart valve disease and those recovering from a recent surgery or procedure are both anxious and concerned. Accordingly, we would like to take this opportunity to share [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/covid-19-advice-for-individuals-with-heart-valve-disease/">Covid-19: Advice for individuals with Heart Valve Disease</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>COVID-19: Consejos para pacientes con valvulopatías cardíacas</title>
		<link>https://www.heartvalvevoice-us.org/covid-19-consejos-para-pacientes-con-valvulopatias-cardiacas/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 17 Mar 2020 14:34:19 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Covid-19]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<category><![CDATA[Spanish]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10391</guid>

					<description><![CDATA[<p>El COVID-19 (Coronavirus) supone un reto sin precedentes para la salud pública a nivel mundial. Su rápida propagación ha provocado significativa alarma así como la suspensión de actividades en el globo. Es muy comprensible que la gente con una valvulopatía y los que se recuperan de alguna intervención quirúrgica reciente, estén angustiados y preocupados. Por [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/covid-19-consejos-para-pacientes-con-valvulopatias-cardiacas/">COVID-19: Consejos para pacientes con valvulopatías cardíacas</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>NIH Issues RFI for Agency-Wide Strategic Plan</title>
		<link>https://www.heartvalvevoice-us.org/nih-issues-rfi-for-agency-wide-strategic-plan/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Wed, 11 Mar 2020 19:41:00 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10373</guid>

					<description><![CDATA[<p>On Feb. 12, 2020, the National Institutes of Health (NIH) issued a Request for Information (RFI) on suggestions to inform the development of a framework for the agency’s Strategic Plan for FYs 2021-2025. The RFI seeks to collect information on several broad themes, including increasing diversity, improving women and minority health, and address public health [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/nih-issues-rfi-for-agency-wide-strategic-plan/">NIH Issues RFI for Agency-Wide Strategic Plan</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
